My Cart [ 0 ]
Home > Antibodies > Anti-Human Antibodies (In Vivo) > Anti-Human CD64 Monoclonal Antibodies

Anti-Human CD64 Monoclonal Antibodies

cluster of differentiation 64, Fc gamma RIA and Fc gamma RIB, Human Fc Receptor Blocking Antibody

Catalog No. Product Name Size List Price (US$) Quantity
PA007393.m1 In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: M22) 1 mg 150.00
PA007393.m1 In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: M22) 5 mg 350.00
PA007393.m1 In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: M22) 25 mg 900.00
PA007393.h1Fs In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: H22) 1 mg 150.00
PA007393.h1Fs In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: H22) 5 mg 350.00
PA007393.h1Fs In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: H22) 25 mg 900.00
Description

Background of Anti-human CD64 Monoclonal Antibody (Clone: M22)

The recombinant M22 or H22 antibody binds to human and non-human primate CD64 or FcγRI, a cluster of differentiation molecule found on monocytes, macrophages, and neutrophils. CD64 plays a central role in macrophage antibody-dependent cellular cytotoxicity and clearance of immune complexes, and is a candidate biomarker for bacterial infection and sepsis.

PA007393.m1: In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Mouse IgG1 Kappa (Clone: M22)

Recombinant mouse IgG1 Monoclonal Antibody. 
Clone: M22.
Isotype: Mouse IgG1 kappa.
Source: The anti-human CD64 monoclonal antibody (clone: M22) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: M22) specifically binds to human CD64.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human CD64 protein. Human Fc receptor blocking solution, human Fc receptor blocking reagent, and human Fc receptor blocking antibody.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

PA007393.h1Fs: In vivo Grade Recombinant Anti-human CD64 Monoclonal Antibody, Human IgG1 Fc Silent Kappa (Clone: H22)

Recombinant human IgG1 monoclonal antibody with Fc silent mutation.
Clone: H22.
Isotype: Human IgG1 kappa.
Source: The anti-human CD64 monoclonal antibody (clone: H22) was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: H22) specifically binds to human CD64.
Applications: ELISA, flow cytometry, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human CD64 protein. Human Fc receptor blocking solution, human Fc receptor blocking reagent, and human Fc receptor blocking antibody.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The antibody is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

The most popular human Fc blocking reagents include:
Anti-human CD16 (clone 3G8), and CD32 (Clone IV.3): for flow cytometry, immunohistochemistry (IHC), and immunoprecipitation (IP). It is highly specific for FcγRII (CD32) and FcγRIII (CD16), and reduces background staining; it may not block all Fc receptors. Clones 10.1, and M22 or H22 are the most widely used anti-human FcγRI (CD64) clone for Fc blocking in flow cytometry and functional assays. It prevents non-specific Fc receptor binding on monocytes, macrophages, and dendritic cells, improving antibody specificity.
Purified human IgGs or mixes of human isotype controls: for general Fc blocking in IHC and immunofluorescence (IF). It is cheap and easy to use but it is less specific, and may even introduce unwanted immunoglobulins. Syd Labs supply various human IgG isotype controls.
Normal mouse serum, purified mouse IgG or isotype controls: for flow cytometry. It can serve as a control to block Fc receptors but it is non-specific for Fc receptors. It is cheap and easy to use but it is less specific, and may even introduce unwanted immunoglobulins. Our recombinant mouse IgG antibody mixes are affordable; the ratio of various IgGs is optimized and adjustable without any unwanted immunoglobulins.
Bovine Serum Albumin (BSA) or FBS: for general blocking in Western Blot (WB) and IHC. They are readily available to reduce non-specific binding but less effective at Fc receptor blocking.
Commercial Fc blocking solutions: for flow cytometry, IHC, and functional assays. They are normally pre-optimized and highly effective but more expensive than DIY solutions. 

Best choice of human Fc blocking reagents based on your application are:
For flow cytometry: anti-human CD16 (Clone 3G8), CD32 (Clone IV.3), and CD64 (Clone 10.1, and M22 or H22).
For Immunohistochemistry (IHC) and Immunofluorescence (IF): Normal mouse serum, purified mouse or human IgGs or isotype controls or commercial Fc blocking kits. Our recombinant mouse IgG antibody mixes and recombinant human IgG isotype controls are affordable; the ratio of various IgGs is optimized and adjustable without any unwanted immunoglobulins.
For Western Blot and ELISA: BSA or FBS.
For functional assays (e.g., blocking Fc-mediated effects): Commercial Fc blocking reagents.

References of Anti-human CD64 Monoclonal Antibody (Clone: M22)

Izumi, et al. Front Immunol. 2021 Mar 5;12:618081. PMID: 33746979; PMCID: PMC7937628
As hematopoietic progenitors supply a large number of blood cells, therapeutic strategies targeting them are potentially beneficial to eliminate unwanted leukemic cells. ...Here, we introduce a dimeric pyrrolobenzodiazepine (dPBD)-conjugated anti-CD64 antibody that selectively induces the apoptosis of proliferating human monocyte-restricted progenitors. ...Given the selective action on proliferating monocyte progenitors, it should be a promising tool to target cancers and inflammatory disorders with minimal side effects.
(Tags: anti-human CD64 clone M22; CD64 monocyte targeting mAb)
Hristodorov, et al. mAbs. 2014;6(5):1283-1289. PMID: 25517313; PMCID: PMC4622438
Tumor necrosis factor (TNF) is a pro-inflammatory cytokine that plays a critical role in inflammatory diseases, typically neutralized by therapeutic monoclonal antibodies. ...However, therapeutic anti-TNF mAbs can be captured by the high-affinity IgG receptor Fc?RI (CD64) expressed on activated macrophages, reducing their availability and efficacy. ...In this study, we demonstrate that a single-chain antibody fragment specifically binds to CD64, preventing the capture of anti-TNF mAbs and potentially enhancing therapies.
(Tags: CD64 blocking antibody M22; anti-human CD64 scFv in vitro)
Mladenov, et al. Oncotarget. 2016 Oct 25;7(43):70295-70305. PMID: 27564103; PMCID: PMC5341865
Fc gamma receptor I (Fc?RI, CD64) is a well-known target antigen for passive immunotherapy against acute myeloid leukemia and chronic myelomonocytic leukemia. ...We recently reported the preclinical immunotherapeutic potential of microtubule associated protein tau (MAP) against a variety of cancer types including breast carcinoma and Hodgkin's lymphoma. ...Here we demonstrate that a CD64-directed human cytolytic fusion protein selectively kills CD64-positive leukemic blasts ex vivo, highlighting its potential for treating CD64-positive leukemias.
(Tags: anti-CD64 therapeutic antibody; CD64 targeting ADC clone M22)
Heo, et al. J Control Release. 2017 Jan 28;246:125-134. PMID: 28003138; PMCID: PMC5294565
Monocytes and macrophages play key roles in various inflammatory diseases, making them highly attractive targets for RNA interference (RNAi) therapeutics. ...To achieve targeted siRNA delivery, we developed a liposomal formulation surface-modified with a human CD64-specific single-chain antibody. ...Our results indicate that this human CD64-targeted delivery system efficiently promotes specific cellular uptake of siRNA and gene silencing in human primary monocytes.
(Tags: anti-human CD64 liposomes; CD64 M22 targeted delivery)
Kopertekh, et al. Front Plant Sci. 2023 Aug 9;14:1229490. PMID: 37637255; PMCID: PMC10444015
Monocytic leukemia is a severe hematological malignancy that requires novel targeted therapies to overcome drug resistance and improve patient outcomes. ...We designed and optimized a set of recombinant immunotoxins targeting the human CD64 receptor, utilizing transient expression in plant systems for rapid production. ...Activity testing of these plant-derived immunotoxins demonstrated robust and specific cytotoxicity against CD64-expressing leukemic cells, validating this platform for biopharmaceutical development.
(Tags: CD64 recombinant immunotoxin; anti-human CD64 clone M22)
For more technical references or data sheets regarding the Recombinant Anti-human CD64 Monoclonal Antibody (Clone: M22) formats, please contact our scientific support team at message@sydlabs.com.

Syd Labs provides the following in vivo grade recombinant anti-human CD16, CD32, and CD64 monoclonal antibodies:
Recombinant Anti-human CD16 monoclonal antibody (Clone: 3G8)
Recombinant Anti-human CD32 monoclonal antibody (Clone: IV.3)
Recombinant Anti-human CD64 monoclonal antibody (Clone: H22)

Syd Labs provides the following in vivo grade recombinant anti-mouse CD16, CD32, and CD64 monoclonal antibodies:
Recombinant Anti-mouse CD16/CD32 monoclonal antibody (Clone: 2.4G2)

Syd Labs provides the following recombinant anti-human CD16, CD32, and CD64 monoclonal antibodies for flow cytometry:
Recombinant Anti-human CD16 monoclonal antibody (Clone: 3G8) for flow cytometry
Recombinant Anti-human CD32 monoclonal antibody (Clone: IV.3) for flow cytometry
Recombinant Anti-human CD64 monoclonal antibody (Clone: H22) for flow cytometry

Related Links

See our Privacy Policy